What is it about?
This article investigates the recovery tendency of bone-related markers after treatments of DKA.The study revealed that the bone turnover of DKA is significantly different in pre-treatment and recovery; however, NMID might recover quickly if the patients received appropriate treatment. Importantly, pancreatic function plays a critical role in changing bone turnover biomarkers.
Featured Image
Photo by Gabin Vallet on Unsplash
Why is it important?
We previously found that patients with DKA were at higher risks of osteoporosis and bone fracture, which may be related to the thyroid function, for thyroid function could affect the bone markers and its cells. In this study, we followed up on the markers associated with bone metabolism and found that after treatment. However, there is a tendency for recovery; full recovery may take time and differ between individuals and normal. The patients' pancreatic functions may partially determine the recovery rate and extent.
Perspectives
If proper treatment is received, the deterioration of bone markers may be hampered by DKA; however, the pancreatic function of a patient may partially determine its bone prognosis.
Dr. Song Wen
Shanghai Pudong Hospital
Read the Original
This page is a summary of: The Evolution of the Bone Turnover Marker in Patients Following
Recovery from Diabetic Ketoacidosis, Hormone and Metabolic Research, February 2024, Thieme Publishing Group,
DOI: 10.1055/a-2247-5610.
You can read the full text:
Resources
Contributors
The following have contributed to this page
